Clinical Trial

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

Name: A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China — clinical trial record (NCT07316062)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MAP

Recruiting

View on ClinicalTrials.gov →

Summary

This chart review study is proposed in China to understand the treatment patterns, biomarker testing, and clinical outcomes with SOC and some selected regimens among patients diagnosed with stage I-III NSCLC.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-14

Trial Details

NCT Number	NCT07316062
Lead Sponsor	AstraZeneca
Conditions	Non-Small-Cell Lung
Enrollment	3,000 participants
Start Date	2026-04-29
Primary Completion	2029-04-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-12